Intellia Therapeutics Inc (NTLA)
20.02
-1.15
(-5.43%)
USD |
NASDAQ |
Apr 25, 16:00
20.01
-0.01
(-0.05%)
After-Hours: 20:00
Intellia Therapeutics Shares Outstanding: 96.11M for Feb. 21, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 21, 2024 | 96.11M |
February 16, 2024 | 96.11M |
December 31, 2023 | 93.00M |
November 03, 2023 | 89.55M |
September 30, 2023 | 89.10M |
July 28, 2023 | 88.49M |
June 30, 2023 | 88.35M |
April 28, 2023 | 88.14M |
April 17, 2023 | 88.14M |
March 31, 2023 | 88.10M |
February 17, 2023 | 88.02M |
December 31, 2022 | 87.10M |
December 02, 2022 | 86.22M |
October 31, 2022 | 78.68M |
September 30, 2022 | 76.59M |
August 01, 2022 | 76.01M |
June 30, 2022 | 76.00M |
April 28, 2022 | 75.85M |
April 18, 2022 | 75.63M |
March 31, 2022 | 75.62M |
February 17, 2022 | 74.67M |
December 31, 2021 | 74.49M |
October 29, 2021 | 74.42M |
September 30, 2021 | 74.34M |
July 30, 2021 | 73.49M |
Date | Value |
---|---|
July 02, 2021 | 73.09M |
June 30, 2021 | 68.33M |
April 30, 2021 | 68.15M |
April 26, 2021 | 68.12M |
March 31, 2021 | 67.89M |
February 19, 2021 | 67.73M |
December 31, 2020 | 66.23M |
December 04, 2020 | 64.59M |
October 30, 2020 | 59.08M |
September 30, 2020 | 58.79M |
July 31, 2020 | 58.74M |
June 30, 2020 | 58.72M |
June 05, 2020 | 58.65M |
May 30, 2020 | 52.35M |
May 01, 2020 | 51.38M |
April 20, 2020 | 51.36M |
March 31, 2020 | 50.60M |
February 21, 2020 | 50.51M |
December 31, 2019 | 50.20M |
October 25, 2019 | 48.88M |
September 30, 2019 | 48.88M |
July 26, 2019 | 48.54M |
June 30, 2019 | 47.71M |
April 30, 2019 | 45.71M |
April 01, 2019 | 45.48M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
45.71M
Minimum
Apr 30 2019
96.11M
Maximum
Feb 16 2024
70.54M
Average
73.49M
Median
Jul 30 2021
Shares Outstanding Benchmarks
Moderna Inc | 382.88M |
Regeneron Pharmaceuticals Inc | 109.76M |
NeuroMetrix Inc | 1.986M |
Repligen Corp | 55.77M |
Pacific Biosciences of California Inc | 267.95M |